A. Ba

Impact of the serogroup A meningococcal conjugate vaccine, MenAfriVac, on carriage and herd immunity.

D. Caugant, T. Clark, P. Kristiansen, 2013, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Carriage of Neisseria lactamica in 1- to 29-Year-Old People in Burkina Faso: Epidemiology and Molecular Characterization

D. Caugant, T. Clark, P. Kristiansen, 2012, Journal of Clinical Microbiology.

Evolution of meningococcal carriage in serogroups X and Y before introduction of MenAfriVac in the health district of Kaya, Burkina Faso

P. Kristiansen, A. Ba, I. Sanou, 2014, BMC Infectious Diseases.

Persistent low carriage of serogroup A Neisseria meningitidistwo years after mass vaccination with the meningococcal conjugate vaccine, MenAfriVac

D. Caugant, T. Clark, P. Kristiansen, 2014, BMC Infectious Diseases.

Carriage and Herd Immunity

Burkina Faso, T. Clark, P. Kristiansen, 2012 .

Meningococcal carriage 7 years after introduction of a serogroup A meningococcal conjugate vaccine in Burkina Faso: results from four cross-sectional carriage surveys

Michael W. Spiller, Ryan T Novak, P. Kristiansen, 2020, The Lancet. Infectious diseases.

Nationwide Trends in Bacterial Meningitis before the Introduction of 13-Valent Pneumococcal Conjugate Vaccine—Burkina Faso, 2011–2013

Ryan T Novak, L. McGee, A. Ba, 2016, PloS one.

Phenotypic and genotypic characterization of meningococcal carriage and disease isolates in Burkina Faso after mass vaccination with a serogroup a conjugate vaccine

D. Caugant, T. Clark, P. Kristiansen, 2013, BMC Infectious Diseases.

Assessment of the Prevalence of Extended-Spectrum Beta Lactamase Producing Gram-Negative Bacilli at the Cdg-Chup, Ouagadougou

Ky, M. Sanou, A. Ba, 2017 .

Impact of the serogroup A meningococcal conjugate vaccine, MenAfriVac, on carriage and herd immunity.

D. Caugant, T. Clark, P. Kristiansen, 2013, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.